false
0001584693
0001584693
2024-10-01
2024-10-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 1, 2024
Healthcare
Integrated Technologies Inc.
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-36564 |
|
85-1173741 |
(State of
Incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
311
S. Weisgarber Road
Knoxville, TN |
|
37919 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
| (865)
237-4448 |
| (Registrant’s
Telephone Number, Including Area Code) |
| |
| (Former
Name or Former Address, if Changed Since Last Report.) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None.
Securities
registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934.
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item
5.02. | Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. |
Full-Time
Chief Financial Officer
Effective
as of October 1, 2024, Timothy R. Brady was appointed by the Board of Directors (the “Board”) of Healthcare Integrated Technologies
Inc. (the “Company”) to the position of Chief Financial Officer. Mr. Brady initially served as our Chief Financial Officer
on a fractional basis and commenced service as Chief Financial Officer on a full-time basis as of December 1, 2024.
Mr.
Brady, age 63, served as a fractional CFO to companies in several industries, including oil and gas, financial services, hospitality,
retail and manufacturing from January 2021 through December 2024. Previously, he served as Chief Financial Officer of Northern Industrial
Sands, a privately held supplier of northern white frac sand, from July 2016 through August
2020 and as Chief Financial Officer and Treasurer of Dakota Plains Holdings, Inc., a publicly traded
midstream energy company, from September 2011 to April 2016. Mr. Brady was instrumental in uplisting the Company from the OTC Pink Sheets
to the NYSE. Before joining Dakota Plains, Mr. Brady served as one of three founders and CFO of Encore Energy, a privately held independent
operator of oil and natural gas properties, from May 2011 through September 2011. Prior to that position, Mr. Brady served as the CFO
from April 2010 through May 2011 of Allied Energy, a publicly traded oil and natural gas company, and served on its board of directors,
where Mr. Brady was able to upgrade the firm to the highest grading level on the OTC Market tier.
In
connection with the commencement of his full-time service to the Company in December, the Company entered into a Non-Employee Chief Financial
Officer Engagement Agreement dated December 1, 2024. Pursuant to the agreement, Mr. Brady is entitled to an initial monthly base salary
of $10,000 and received 2,000,000 shares of the Company’s common stock. The Board or its compensation committee may grant Mr. Brady
other long-term incentive awards in the form of equity awards, cash incentives or otherwise, from time to time and in the discretion
of the Board or its committee. Mr. Brady is also entitled to a 2% override on any and all Company sales, including initial sales and
subsequent recurring sales. No overrides will be considered earned by the Company until the amount is collected from the customer. The
Company has agreed to pay Mr. Brady an annual bonus subject to achievement by the Company of Board-established corporate goals and to
recognized other achievements by the Company or Mr. Brady during the year. Mr. Brady is entitled to participate in any employee benefit
plans, programs and arrangements of the Company in effect during the engagement period which are generally available to other senior
executives of the Company (including, without limitation, group medical insurance plans, life insurance plans, and 401(k) plans), subject
to and on a consistent basis with the terms, conditions and overall administration of such plans, programs and arrangements.
Promotion
to President
Effective
January 1, 2025, our Board promoted Dustin M. Hillis to the role of President in addition to his existing role of Chief Strategy Officer.
Mr. Hillis, age 42, has served as our Chief Strategy Officer since June 2024. He brings a wealth of experience and a proven history of
success to the Company. Mr. Hillis has also served as Chief Strategy Officer for Tough Stump Technologies, a veteran-owned small business
harnessing unmanned aircraft systems technology with a communications ecosystem through mapping, drones, training, and software, since
June 2023 and for Totally Mushrooms, a supplier for commercial mushroom farming, since August 2023. Previously, Mr. Hillis served as
Chief Executive Officer the Southwestern Family of Companies, a global conglomerate, from July 2018 to August 2022, where he managed
and expanded twenty diverse international businesses with a workforce of over 2,000 individuals worldwide. Scott M. Boruff, our current
Chief Executive Officer and Chairman of the Board, previously held the title of President and there has been no other change to his roles
with the Company.
In
connection with the commencement of his promotion, the Company entered into a Non-Employee President & Chief Strategy Officer Engagement
Agreement dated January 1, 2025. Pursuant to the agreement, Mr. Hillis is entitled to an initial annual base salary of $100,000. He is
also entitled to a 5% commission on the gross amount of any and all Company revenue collected from customers, including initial sales
and subsequent recurrent sales. The Company has agreed to pay Mr. Hillis a bonus from time to time and in such amounts as may be determined
by the Board. Mr. Hillis is entitled to participate in any employee benefit plans, programs and arrangements of the Company in effect
during the engagement period, subject to and on a consistent basis with the terms, conditions and overall administration of such plans,
programs and arrangements.
There
are no arrangements or understandings between either Mr. Brady or Mr. Hillis and any other person or persons pursuant to which he was
selected to serve in an executive officer position. Neither Mr. Brady nor Mr. Hillis is related to any of our other executive officers
or directors. There are no current or proposed transactions in which either Mr. Brady or Mr. Hillis, or any member of their respective
immediate families, has an interest that is required to be disclosed under Item 404(a) of Regulation S-K promulgated by the U.S. Securities
and Exchange Commission.
| Item
9.01. | Financial
Statements and Exhibits. |
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf
by the undersigned hereunto duly authorized.
| |
Healthcare
Integrated Technologies Inc. |
| |
|
|
| Date:
February 24, 2025 |
By: |
/s/
Scott M. Boruff |
| |
|
Scott
M. Boruff |
| |
|
Chief
Executive Officer |
Exhibit
10.1
NON-EMPLOYEE
CHIEF FINANCIAL OFFICER
ENGAGEMENT
AGREEMENT
This
Non-Employee Chief Financial Officer Agreement (the “Agreement”) is effective as of the 1st day of December
1, 2024 (the “Effective Date”) by and between HEALTHCARE INTEGRATED TECHNOLOGIES, INC., a Nevada corporation
(the “Company”), and Timothy R. Brady (“Executive”).
NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and conditions contained herein, the parties hereto agree as
follows:
1. Engagement. The
Company hereby engages Timothy R. Brady, to perform those Non-employee Chief Financial Officer (“CFO”) duties as defined
by the Chief Executive Officer (“CEO”) and/or Board of Directors (“BOD”) and such other reasonable duties as
may be requested from time to time by the CEO and/or BOD of the Company. Mr. Brady (“Executive”) hereby accepts such
engagement upon the terms and subject to conditions set forth in this Agreement.
2. Non-employee
Chief Financial Officer. The Company agrees to designate Executive as CFO of the Company to perform those duties of CFO for the
Company as defined herein. Executive shall provide services as CFO of Company. In addition, the Executive will also serve as the
Company’s Secretary and Treasurer.
3. Compensation.
A.
Base Fee. Effective December 1, 2024, for the services rendered by Executive under this Agreement, the Executive will be
paid a monthly base fee of $10,000. At the discretion of the Board of Directors, Executive’s Base Fee may be increased.
B. Equity
Incentives. In addition to base contract pay, Executive shall be entitled to the following equity incentive awards:
(i) Stock
Grant. The Executive shall be granted by the Company a stock grant of 2,000,000 shares of the Company’s common stock. The stock
grant shall be non-qualified and shall become fully vested upon execution of this agreement.
(ii) Long-Term
Incentives. The Board or Committee may grant Executive other long-term incentive awards, in the form of equity awards or cash incentives
or otherwise, from time to time and in the discretion of the Board or Committee.
C. Sales
Override. Executive shall be paid a 2.0% override on any and all Company sales – initial sales and subsequent recurring
sales. No overrides will be considered earned by the Company until the amount is collected from the customer.
D.
Achievement Bonus Fee. The Company shall pay Executive an Achievement Bonus Fee annually based upon achievement by the
Company of its corporate goals as established and determined by the Board annually and for other achievements by the Company or Executive
during the year as approved by the Board of Directors. The Board of Directors shall, in their respective sole discretion, determine whether
such corporate or other goals have been attained or other achievements have occurred.
E. Benefits.
During the term of this Agreement, Executive shall be entitled to participate in any employee benefit plans, programs and arrangements
of the Company in effect during the engagement period which are generally available to senior executives of the Company (including, without
limitation, group medical insurance plans, life insurance plans, 401(k), subject to and on a basis consistent with the terms, conditions
and overall administration of such plans, programs and arrangements.
4. Term
and Survivability. The term of this Agreement shall be for a period of thirty-six (36) months, beginning on the Effective
Date. Notwithstanding the foregoing, either party shall have the right to terminate this Agreement at any time, with or without cause.
If Executive is terminated for cause, it shall become effective immediately upon written notice to the other party. If Executive is terminated
without cause, this Agreement shall be terminated upon sixty (60) days written notice.
5. Termination
Fee. If Executive is terminated for any reason other than for cause or by voluntary termination by the Company, the Executive
shall be entitled to receive a termination fee equal to three (3) months base pay at the rate in effect at such time as defined in Section
3A above.
6.
Termination.
A. Voluntary Termination: In the event Agreement is terminated because Executive voluntarily terminates the engagement
before the termination date as defined in Section 5, then:
(1). Company
will not pay the engagement termination fee, or any portion thereof to the Executive; and
(2). Executive
will receive any unpaid portion of the engagement fee through the date of termination.
B.
Change in Control. If at any time during the term of the engagement, Executive is terminated not for Cause within two (2)
years after the Change in Control (as hereinafter defined) or in the ninety (90) days prior to the Change in Control upon the request
of the acquiror, the Company shall pay to Executive an amount equal to 2.99 multiplied by Executive’s maximum
annual Base Fee as described in Section 3A., payable in a lump-sum payment within fifteen (15) days of termination, but not earlier than
the closing of the Change in Control. For purposes hereof, a “Change in Control” means the acquisition by any
Person (as defined below) of beneficial ownership of securities of the Company representing greater than 50% of the combined voting power
of the Company’s then outstanding voting securities. Person means any individual or entity (or group(s) thereof acting together),
which such individual or entity (or group thereof) is not a beneficial owner of any of the Company’s securities as of the date
of this Agreement.
C.
Termination for Cause. In the event Agreement is terminated by the Company because Executive: (i) is convicted of (including
a plea of guilty or no contest as to) any crime (whether or not involving the Company) constituting a felony, indictable offense, or
offense punishable by incarceration in excess of six months; (ii) has engaged in any substantiated act involving moral turpitude; (iii)
Executive’s gross neglect or misconduct in the performance of engagement duties including the willful failure or refusal to perform
such duties as may reasonably be assigned to Executive by the Board of Directors of the Company consistent with Executive’s CFO
position, or (iv) a material breach of any provision of this Agreement; provided, however, that with respect to clauses (iii) or (iv),
the Company will give to Executive advance notice so that they will have at least ten (10) business days to cure any such breach, the
engagement Termination Fee will not be payable; provided that in such event, however, the Company would pay to Executive amounts due
to Executive pursuant to Section 3 hereof prorated to the date of such termination.
D.
By Death. The Agreement shall terminate automatically upon the death of Executive. In such event, the Company shall pay
to Executive or his estate any accrued but unpaid Base Fee and any Achievement Bonus Fees to the extent earned.
7. Costs
and Expenses of Executive Performance. All costs and expenses of Executive performance hereunder shall be borne by the
Company upon submission and approval of documentation of such costs and expenses in accordance with the Company’s expense reimbursement
policy.
8. Independent
Contractor. Company and Executive individually shall not be deemed to be employees or agents of the Company for any purpose whatsoever.
Executive shall have the supervisory control over the accounting employees, accounting related consultants or independent contractors
who provide accounting/consulting services to the Company.
9. Taxes.
As an independent contractor, Executive acknowledges and agrees that it is solely responsible for the payment of any taxes and/or assessments
imposed on account of the payment of compensation to, or the performance of services by Executive pursuant to this Agreement, including,
without limitation, any unemployment insurance tax, federal and state income taxes, federal Social Security (FICA) payments, and state
disability insurance taxes. The Company shall not make any withholdings or payments of said taxes or assessments with respect to amounts
paid to Executive hereunder; provided, however, that if required by law or any governmental agency, the Company shall withhold such taxes
or assessments from amounts due to Executive, and any such withholding shall be for Executive’s account and shall not be reimbursed
by the Company to the Executive. Executive expressly agrees to make all payments of such taxes, as and when the same may become due and
payable with respect to the compensation earned under this Agreement.
10. Confidentiality. For
a period of twenty-four (24) months from the termination of this Agreement, Executive agrees that they will not, except when required
by applicable law or order of a court, during the term of this Agreement or thereafter, disclose directly or indirectly to any person
or entity, any Trade Secrets (as defined below) or Confidential Information (as defined below) or other information treated as confidential
by the Company known, learned or acquired from the Company by the Executive during the period of the Executive’s engagement by
the Company. For purposes of this Agreement, “Confidential Information” shall mean any and all Trade Secrets, knowledge,
data or know-how of the Company, any of its affiliates, or proprietary information of third parties in the possession of the Company
or any of its affiliates, and any nonpublic technical, training, financial and/or business information treated as confidential by the
Company or any of its affiliates, including such information, knowledge, Trade Secret or data conceived, originated, discovered or developed
by the Executive hereunder. For purposes of this Agreement, “Trade Secrets” shall include, without limitation, any formula,
concept, pattern, processes, designs, device, software, systems, list of customers, training manuals, marketing or sales or service plans,
business plans, marketing plans, financial information, or compilation of information which is used in the Company’s business or
in the business of any of its affiliates.
Confidential
Information and Trade Secrets shall not include, and the foregoing shall not apply to, information that is (i) generally available to
the public other than a result of a disclosure by Executive; (ii) available to Executive on a non-confidential basis prior to the disclosure
by Company to Executive; (iii) available to the Executive on a non-confidential basis from a source other than Company or its affiliates,
provide, however, that such source is not bound by a confidentiality agreement; or (iv) required to be disclosed by Executive by law
or pursuant to court order. Executive shall notify the Company of any information that comes to its attention that might indicate that
there has been a loss of confidentiality with respect to the Confidential Information.
11. Return
of the Company’s Proprietary Materials. Executive agrees to deliver promptly to the Company on termination of this
Agreement for whatever reason, or at any time the Company may so request, all documents, records, artwork, designs, data, drawings, flowcharts,
listings, models, sketches, apparatus, notebooks, disks, notes, copies and similar repositories of Confidential Information and any other
documents of a confidential nature belonging to the Company, including all copies, summaries, records, descriptions, modifications, drawings
or adaptations of such materials which Executive may then possess or have under its control. Executive further agrees that upon termination
of this Agreement, shall not retain any document, data or other material of any description containing any Confidential Information or
proprietary materials of the Company.
12. Assignment
of Proprietary Rights. Executive hereby assigns and transfers to the Company all right, title and interest that Executive may
have, if any, in and to all Proprietary Rights (whether or not patentable or copyrightable) made, conceived, developed, written or first
reduced to practice by Executive, whether solely or jointly with others, during the period of Executive’s engagement by the Company
which directly relate to and claim an improvement upon the technology or intellectual property owned by the Company.
Executive
acknowledges and agrees that the Company shall have all right, title and interest in, among other items, all research information and
all documentation or manuals related thereto that Executive develops or prepares for the Company hereunder during the period of Executive’s
engagement by the Company and that such work by Executive shall be work made for hire and that the Company shall be the sole author thereof
for all purposes under applicable copyright and other intellectual property laws. With respect to all Proprietary Rights which are assigned
to the Company pursuant to this Section 12, Executive will assist the Company in any reasonable manner for reasonable compensation to
obtain for the Company’s benefit patents and copyrights thereon in any and all jurisdictions as may be designated by the Company,
and Executive will execute, when requested, patent and copyright applications and assignments thereof to the Company, or other persons
designated by the Company, and any other lawful documents deemed necessary by the Company to carry out the purposes of this Agreement.
13. Trade
Secrets of Others. Executive represents to the Company that its performance of all the terms of this Agreement does not
and will not breach any agreement to keep in confidence proprietary information or trade secrets acquired by Executive in confidence
or in trust prior to its engagement by the Company, and Executive will not disclose to the Company, or induce the Company to use, any
confidential or proprietary information or material belonging to others. Executive agrees not to enter into any agreement, either written
or oral, in conflict with this Agreement.
14. Other
Obligations. Executive acknowledges that the Company, from time to time, may have agreements with other persons which impose
obligations or restrictions on the Company regarding proprietary rights made or developed during the course of work thereunder or regarding
the confidential nature of such work. Executive agrees to be bound by all such obligations and restrictions made known to him in writing
by the Company and to act as may be reasonably required to discharge the obligations of the Company thereunder.
15. Directors
and Officers Insurance. The Company shall, at its own expense, always maintain a minimum of $1,000,000 (One Million Dollars)
Directors and Officers insurance.
16. Key
Man Insurance. Company shall have the right to secure, in its own name or otherwise, and at its own expense, life, disability,
accident or other insurance covering Executive and Executive shall have no right, title or interest in or to such insurance. Executive
shall assist Company in procuring such insurance by submitting to reasonable examinations and signing such applications and other instruments
as may be required by the insurance carriers to which applications is made for any such insurance.
17. Indemnification. The
Company shall, at its own expense, defend, indemnify and hold harmless the Executive from and against any and all liabilities, claims,
actions, losses, costs and expenses (including reasonable attorneys’ fees and disbursements) (i) relating to or arising out of
the Company’s actual or alleged violation of any law, statute, ordinance, order, rule or regulation; or (ii) to the extent such
Claim is primarily and directly based upon information or direction provided by the Company to Executive provided, however, the foregoing
shall not apply to any portion of such Claims to the extent it is found to have resulted primarily and directly from Executive’s
(A) infringement of any United States patent, foreign letters patent, license, trademark, copyright, trade secret or any other proprietary
right other than as may be directed or induced by the Company for the services provided by Executive hereunder; (B) breach of this Agreement
or any other agreement; (C) violation of any law, statute, ordinance, order, rule or regulation; or (D) any negligence or intentional
misconduct in connection with such performance. This indemnification is not voided by the termination of this agreement.
18. Non-Solicitation.
Executive will not, during the term this Agreement and for one year thereafter, directly or indirectly (whether as an owner, partner,
shareholder, agent, officer, director, employee, independent contractor, consultant, or otherwise) with or through any individual or
entity: (i) employ, engage or solicit for employment any individual who is, or was at any time during the twelve-month period immediately
prior to the termination of this Agreement for any reason, an employee of the Company, or otherwise seek to adversely influence or alter
such individual’s relationship with the Company; or (ii) solicit or encourage any individual or entity that is, or was during the
twelve-month period immediately prior to the termination of this Agreement for any reason, a customer or vendor of the Company to terminate
or otherwise alter his, her or its relationship with the Company or any of its affiliates.
19. Equitable
Remedies. In the event of a breach or threatened breach of the terms of this Agreement by Executive, the parties hereto
acknowledge and agree that it would be difficult to measure the damage to the Company from such breach, that injury to the Company from
such breach would be impossible to calculate and that monetary damages would therefore be an inadequate remedy for any breach. Accordingly,
the Company, in addition to any and all other rights which may be available, shall have the right of specific performance, injunctive
relief and other appropriate equitable remedies to restrain any such breach or threatened breach without showing or proving any actual
damage to the Company.
20. Governing
Law. This Agreement shall be governed, construed and interpreted in accordance with the internal laws of the state of Tennessee.
21. Entire
Agreement: Modifications and Amendments. The terms of this Agreement are intended by the parties as a final expression of
their agreement with respect-to such terms as are included in this Agreement and may not be contradicted by evidence of any prior or
contemporaneous agreement. This Agreement may not be modified, changed or supplemented, nor may any obligations hereunder be waived or
extensions of time for performance granted, except by written instrument signed by the parties or by their agents duly authorized in
writing or as otherwise expressly permitted herein.
22. Prohibition
of Assignment. This Agreement and the rights, duties and obligations hereunder may not be assigned or delegated by Executive
without the prior written consent of the Company. Any assignment of rights or delegation of duties or obligations hereunder made without
such prior written consent shall be void and of no effect.
23. Approval
of Public Communications and Press Releases. Executive and Company agree that any public announcement regarding Executive must
be approved by Executive in advance.
24. Binding
Effect: Successors and Assignment. This Agreement and the provisions hereof shall be binding upon each of the parties, their
successors and permitted assigns.
25. Validity. This
Agreement is intended to be valid and enforceable in accordance with its terms to the fullest extent permitted by law. If any provision
of this Agreement is found to be invalid or unenforceable by any court of competent Jurisdiction, the invalidity or unenforceability
of such provision shall not affect the validity or enforceability of all the remaining provisions hereof.
26. Notices. All
notices and other communications hereunder shall be in writing and, unless otherwise provided herein, shall be deemed duly given if delivered
personally or by telecopy or mailed by registered or certified mail (return receipt requested) or by Federal Express or other similar
courier service to the parties at the following addresses or (at such other address for the party as shall be specified by like notice):
(i)
If to the Company:
Healthcare
Integrated Technologies, Inc.
311
S. Weisgarber Road
Knoxville,
TN 37919
(ii)
If to Executive:
Timothy
R. Brady
Any
such notice, demand or other communication shall be deemed to have been given on the date personally delivered or as of the date received.
[SIGNATURES
APPEAR ON THE FOLLOWING PAGE]
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the day and year first above written.
| /s/
Timothy R. Brady |
|
| By: |
Timothy
R. Brady |
|
Action
by Unanimous Written Consent of the Board of Directors of Healthcare Integrated Technologies, Inc.
The
undersigned Board of Directors of Healthcare Integrated Technologies, Inc., a Nevada corporation, in lieu of a meeting for such purposes,
does hereby waive all requirements as to notice of such a meeting and hereby authorizes the approval of this Employment Agreement by
written consent.
| /s/
Scott M. Boruff |
|
| By:
|
Scott
M. Boruff |
|
| Its:
|
Chairman
and CEO |
|
Exhibit
10.2
NON-EMPLOYEE
PRESIDENT & CHIEF STRATEGY OFFICER
ENGAGEMENT
AGREEMENT
This
Non-Employee President Agreement (this “Agreement”) is entered into as of the 1st day of January, 2025
(the “Agreement Date”), by and between Healthcare Integrated Technologies, Inc., a Nevada corporation (the
“Company”), and All Things New Ventures, LLC (“Management Company”).
NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and conditions contained herein, the parties hereto agree as
follows:
1. Engagement.
The Company hereby engages Dustin Hillis, Manager of Management Company to serve the Company under the terms of this Agreement, for a
term of three (3) years (the “Initial Term”). On the three (3) year anniversary of the Commencement Date and
each successive one-year anniversary thereafter, the term of this Agreement shall automatically be extended for an additional period
of one (1) year; provided, however, that either party hereto may elect not to extend this Agreement by giving written
notice to the other party at least sixty (60) days prior to any such anniversary date. The Initial Term and any renewal periods thereafter,
until the termination of Executive’s services hereunder, shall be the “Services Period.”
2. Non-employee
President and Chief Strategy Officer. Management Company agrees to designate Dustin Hillis as President and Chief Strategy Officer
of the Company on the terms and conditions set forth in this Agreement. During the Services Period, Management Company shall report directly
to the Chief Executive Officer, and exercise such authority, perform such executive duties and functions and discharge such executive
responsibilities as are reasonably associated with Management Company’s position, consistent with the responsibilities assigned
to officers of companies comparable to the Company, commensurate with the authority vested in Management Company pursuant to this Agreement
and consistent with the Articles of Incorporation and By-laws of the Company. Without limiting the generality of the foregoing, Management
Company shall undertake his duties in a manner consistent with the best interests of the Company and shall perform his duties to the
best of his ability and in a diligent and proper manner. Management Company shall perform all duties, services and responsibilities in
accordance with the guidelines, policies and procedures established by the Board of Directors (the “Board”)
from time to time. Management Company further agrees to devote his time, attention, full skill and best efforts to the interests and
business of the Company.. Notwithstanding the foregoing, nothing in this Agreement shall restrict the Management Company from devoting
time to serve on corporate boards (subject to Board approval), passive personal investments, other business affairs (including, without
limitation, in respect to Management Company’s existing consulting business), educational and charitable interests, provided that
none of such activities, individually or in the aggregate, interferes with the performance of his duties and responsibilities hereunder
or conflicts or competes with the interests of the Company. Management Company individually shall not be deemed to be an employee or
agents of the Company for any purpose whatsoever, it being understood and agreed by Management Company and the Company that Management
Company shall be an independent contractor of the Company.
3. Compensation.
(a) Base
Fee. The Company shall pay to Management Company, as compensation for the performance of his duties and obligations under this
Agreement, a base salary at the rate of $100,000.00 per annum during the Services Period. Management Company’s base salary is payable
in arrears in accordance with the normal payroll practices of the Company for its executive officers. Management Company’s base
salary shall be subject to review each calendar year by the Board in its sole discretion, provided that in no event may the base salary
be reduced from the level previously in effect.
(b) Discretionary
Bonus. The Management Company may be awarded a bonus from time to time and in such amounts as may be determined by the Board
of Directors of the Company in their sole discretion.
(c) Equity
Incentives. In addition to base salary, Management Company shall be entitled to the following equity incentive awards:
(i) Long-Term
Incentives. The Board or Committee may grant to Management Company other long-term incentive awards, in the form of equity awards
or cash incentives or otherwise, from time to time and in the discretion of the Board or Committee.
(d) Revenue
Commissions. Management Company shall be paid a 5.0% commission on the gross amount of any and all Company revenue – initial
sales and subsequent recurring sales – including, without limitation, with respect to software licensing fees, support services,
and maintenance fees (collectively, “Commissions”). No Commissions will be considered earned by the Company
until the amount is collected from the customer. All Commissions shall be payable by the Company to Management Company within thirty
(30) days of the Company’s receipt of the applicable payment from the customer. The Company shall: (i) maintain true and correct
books and records regarding all such customer payments and its calculation of the Commissions payable to Management Company hereunder;
(ii) deliver to Management Company a monthly report detailing the Commission amounts earned by and payable to Management Company, together
with all other relevant information regarding the customer payments relating to such Commissions; and (iii) at the request of Management
Company from time to time, provide Management Company with access to the Company’s books and records to permit Management Company
or his designee(s) to audit the Company’s determinations regarding the calculation and payment of Commissions hereunder.
(e) NoBenefits.
During the Services Period, Management Company shall be entitled to participate in the employee benefit plans, programs and arrangements
of the Company.
(f) Expenses.
In addition to any amounts payable to Management Company pursuant to this Section 3, the Company shall reimburse Management Company,
upon production of accounts and vouchers or other reasonable evidence of payment by Management Company, all in accordance with the Company’s
regular procedures in effect from time to time, all reasonable and ordinary expenses as shall have been incurred by him in the performance
of his duties hereunder or other expenses agreed upon in writing by the Company and Management Company.
4. Termination.
(a) Termination
by the Company for Cause. The Company may terminate Management Company’s services hereunder at any time for Cause. For
purposes of this Agreement, “Cause” shall mean:
(i) Management
Company’s commission of (A) any material violation of law, (B) any breach of fiduciary duty or act of gross negligence or malfeasance,
(C) any act of fraud, or (D) any determination that the Management Company is subject to any “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualifying Event”), except for a Disqualifying
Event covered by Rule 506(d)(2) or (d)(3);
(ii) Management
Company’s commission of any other act of moral turpitude injurious to the Company, which the Board in its sole discretion determines
has or may be reasonably expected to have a detrimental impact on the Company’s business or operations or would prevent Management
Company from effectively performing his duties under this Agreement;
(iii) a
material breach by Management Company of any obligations or covenants contained in this Agreement as determined by the Board in its sole
discretion, provided that the Company has given Management Company written notice of the existence of such material breach and at least
ten (10) business days to cure such material breach (provided, further, that if Management Company is making diligent efforts to cure
such material breach and cannot reasonably do so within such ten (10) business day period, such period shall be extended to provide Management
Company the opportunity to so cure such material breach (such extension not to exceed twenty (20) business days)), and Management Company
has failed to so cure such material breach; and
(iv) a
material failure by Management Company to discharge his duties, responsibilities and obligations under this Agreement, or a failure to
follow the directives of the Board, as determined by the Board in its sole discretion, provided that the Company has given Management
Company written notice of the existence of such material failure and at least ten (10) business days to cure such material failure (provided,
further, that if Management Company is making diligent efforts to cure such material failure and cannot reasonably do so within such
ten (10) business day period, such period shall be extended to provide Management Company the opportunity to so cure such material failure
(such extension not to exceed twenty (20) business days)), and Management Company has failed to so cure such material failure.
(b) Termination
Upon Death or Disability. The Services Period shall be terminated upon the death or Disability (as defined below) of Management
Company. “Disability” shall mean that as a result of physical or mental illness, injury, infirmity or other
incapacity as determined by a physician selected by the Board, Management Company is not able to substantially perform his duties and
responsibilities to the Company for a period of one hundred twenty (120) consecutive days or an aggregate period of more than one hundred
and eighty (180) days in any 12-month period.
(c) Termination
by the Management Company without Good Reason. The Management Company may terminate this Agreement for any reason upon sixty
(60) days prior written notice to the Company.
(d) Termination
by the Execution with Good Reason. The Management Company may termination this Agreement immediately upon written notice to the Company
with Good Reason. For purposes hereof, “Good Reason” shall mean a voluntary termination by Management Company
of this Agreement if (a) any of the following events occur without Management Company’s express prior written consent; (b) within
thirty (30) days after Management Company learns of the occurrence of such event, Management Company gives written notice to the Company
describing such event and demanding cure; and (c) such event is not fully cured within ten (10) business days after such notice is given:
(i) a reduction in Management Company’s compensation, (ii) a material breach by the Company (or any principal or affiliate of the
Company) of any term(s) of this Agreement, (iii) an adverse change in Management Company’s title, status, authority, duties or
responsibilities, or (iv) a relocation of Management Company’s work location
(e) Termination
Date. If Management Company is terminated by the Company for Cause, or Management Company voluntarily terminates this
Agreement for Good Reason or dies or suffers a Disability, any such termination shall become effective immediately upon written notice
thereof (or, in the case of Management Company’s death, on the date of such death). If Management Company is terminated by the
Company without Cause or Management Company voluntarily terminates without Good Reason, the termination of this Agreement shall be effective
upon the conclusion of the applicable notice period. The date on which the termination of this Agreement becomes effective shall be hereinafter
referred to as the “Termination Date.” For the avoidance of doubt, if this Agreement expires without renewal or extension
at the conclusion of the Initial Term or any subsequent renewal term, such expiration date shall be deemed the Termination Date.
5. Consequences
of Termination.
(a) For
Cause, Death, Disability or Non-Renewal; By Management Company without Reason. In the event of termination of Management Company’s
services at any time during the Services Period (i) by the Company for Cause pursuant to Section 4(a), (ii) by Management Company without
Good Reason pursuant to Section 4(c), (iii) by either party as a result of a non-renewal in accordance with Section 1 hereof, or (iv)
as a result of death or Disability pursuant to Section 4(b), Management Company shall be entitled only to receive base salary accrued
but not paid through the date of termination and, in the case of termination due to death or Disability, a pro rata payment of the annual
incentive earned for the year of termination, as specified in Section 5(e), and the Company shall have no further obligations to Management
Company.
(b) Other
Termination. In the event of a termination of this Agreement by the Company without Cause or by Management Company with Good
Reason:
The
Company shall provide to Management Company base salary accrued but not paid through the date of termination plus, as severance, base
salary for one year, payable over time in accordance with the Company’s normal payroll practices, provided that, in the event such
termination occurs after the end of the Initial Term, Management Company shall be entitled only to receive base salary accrued but not
paid through the date of termination; and
(i) The
Company will pay to Management Company all Commissions: (a) all Commissions earned by Management Company but not paid by the Company
prior to the Termination Date; and (b) in respect of the customers of the Company as of the Termination Date, all Commissions that would
have been earned by Management Company on or before the one-year anniversary of the Termination Date if this Agreement had not been so
terminated (the Commissions described in the foregoing clauses (a) and (b) being hereinafter referred to as the “Post-Termination
Commissions”). All such Post-Termination Commissions shall be paid in the amounts and at the times such Post-Termination Commissions
would otherwise have been paid to Management Company if this Agreement had not been so terminated.
(ii) The
Company will pay Management Company a pro rata portion of any discretionary bonus referenced in Section 3(b) that would otherwise have
been payable to Management Company for the applicable period(s) if this Agreement had not been so terminated, with the amount and timing
for payment of any such discretionary bonus being determined by reference to the discretionary bonuses (if any) paid or payable to other
similarly-situated Management Companys of the Company for the applicable period(s).
(iii) The
Company shall pay to Management Company a pro rata payment of the annual incentive earned for the year of termination, as specified in
Section 5(e); and
(iv) The
provisions of Section 5(b)(i) notwithstanding, if the aggregate value of those installment payments of severance under Section 5(b)(i)
that do not constitute “short-term deferrals” under Treasury Regulation § 1.409A-1(b)(4) exceeds the maximum amount
that would be excluded from being a deferral of compensation by operation of the “two-year/two-times” exclusion under Treasury
Regulation § 1.409A-1(b)(9)(iii), such excess amount shall be payable in installments during the applicable short-term deferral
period following Management Company’s termination of this Agreement.
(c) Change
in Control. If at any time during the Services Period, Management Company’s services to the Company is terminated by the
Company not for Cause within two (2) years after the Change in Control (as hereinafter defined) or in the ninety (90) days prior to the
Change in Control upon the request of the acquiror, the Company shall pay to Management Company an amount equal to 2.99 multiplied
by Management Company’s annualized salary that Management Company is then earning, payable in a lump-sum payment at the applicable
time specified in Section 5(d) but not earlier than the closing of the Change in Control. For purposes hereof, a “Change
in Control” means the acquisition by any Person (as defined below) of beneficial ownership of securities of the Company
representing greater than 50% of the combined voting power of the Company’s then outstanding voting securities. Person means any
individual or entity (or group(s) thereof acting together), which such individual or entity (or group thereof) is not a beneficial owner
of any of the Company’s securities as of the date of this Agreement. In addition, in the case of such a termination the Company
shall pay to Management Company the annual incentive earned for the year of termination (without pro ration), as specified in Section
5(e), and the payments specified in Sections 5(b)(ii) and 5(b)(iii).
(d) Obligation
to Execute Release. The Company’s obligation to make the payments provided for in Section 5(b) or 5(c) (the “Termination
Payments”) shall be subject to Management Company’s execution of a release in favor of the Company, in form and substance
acceptable to the Company, which release is not revoked by Management Company by the end of any applicable revocation period and is thereafter
non-revocable. The Company will supply to Management Company a form of the release (which shall include the Management Company’s
obligations under Section 7) not later than the date of Management Company’s termination, which must be returned within the time
period required by law and must not be revoked by Management Company within the applicable time period (if any) such that the release
becomes legally effective. If no time period for execution or revocation applies under applicable law, the release must be executed and
returned to the Company within fifteen (15) days. If any amount payable during a fixed period following Management Company’s termination
is subject to the requirement or condition that Management Company has executed and not revoked such release (including any case in which
such fixed period would begin in one year and end in the next), the Company, in determining the time of payment of any such amount, will
not be influenced by Management Company or the timing of any action of Management Company, including Management Company’s execution
of such a release and expiration of any revocation period. In particular, the Company retains discretion to deposit any payment hereunder
in escrow at any time during such fixed period, so that such deposited amount is constructively received and taxable income to Management
Company upon deposit (it may be constructively received even in the absence of such deposit) but with distribution from such escrow remaining
subject to Management Company’s execution and non-revocation of such release.
(e) Annual
Incentive Payable In Connection with Termination. If upon termination of this Agreement, Management Company becomes entitled
to be paid the annual incentive (or a pro rata portion thereof) for the year of termination under Section 5(a), 5(b) or 5(c), the following
terms shall apply:
(i) The
annual incentive will be based on the actual performance achieved in the full fiscal year in which the termination occurred, without
any exercise of negative discretion by the Board or any committee thereof;
(ii) The
pro rata portion (if applicable) shall be determined by dividing the number of days from the beginning of the fiscal year to the Termination
Date by 365;
(iii) The
annual incentive shall be payable not later than the time the annual incentive would have been paid in the absence of termination of
this Agreement.
(f) Withholding
of Taxes. No payments required to be made by the Company to Management Company under this Agreement shall be subject to withholdings
or deductions unless expressly required pursuant to any applicable law or regulation.
(g) No
Other Obligations. Except for the obligations of the Company provided by this Agreement and by operation of applicable law, the
Company shall have no further obligations to Management Company upon termination of this Agreement.
6. Director
and Officer Insurance. The Company shall, at its own expense, always maintain a minimum of $1,000,000 (One Million Dollars) Directors
and Officers insurance.
7. Key
Man Insurance. Company shall have the right to secure, it its own name or otherwise, and at its own expense, life, disability,
accident or other insurance covering Executive and Executive shall have no right, title or interest in or to such insurance. Executive
shall assist Company in procuring such insurance by submitting to reasonable examinations and signing such applications and other instruments
as may be required by the insurance carriers to which applications is made for any such insurance.
8. Indemnity. The
Company shall, at its own expense, defend, indemnify and hold harmless the Management Company and Management Company’s employees,
consultants or independent contractors who provide services for Company on behalf of Management Company from and against any and all
liabilities, claims, actions, losses, costs and expenses (including reasonable attorneys’ fees and disbursements) (collectively,
“Claims”): (i) relating to or arising out of the Company’s actual or alleged violation of any law, statute,
ordinance, order, rule or regulation; (ii) to the extent such Claim is primarily and directly based upon information or direction provided
by the Company to Management Company and Management Company’s employees, consultants and independent contractors; provided, however,
the foregoing shall not apply to any portion of such Claims to the extent it is found to have resulted primarily and directly from Managment
Company’s (A) infringement of any United States patent, foreign letters patent, license, trademark, copyright, trade secret or
any other proprietary right other than as may be directed or induced by the Company for the services provided by Management Company here
under; (B) breach of this Agreement or any other agreement; (C) violation of any law, statute, ordinance, order, rule or regulation;
or (D) any negligence or intentional misconduct in connection with such performance. This indemnification is not voided by the termination
of this agreement.; (iii) relating to or arising out of the Company’s actual or alleged breach of this Agreement; or (iv) relating
to or arising in connection with Management Company’s performance of the services described herein. In addition to, and not in
lieu of, the foregoing, the Company shall, during the Services Period and thereafter, indemnify Management Company to the fullest extent
permitted by law and by its Articles of Incorporation and By-laws and shall assure that Management Company is covered by the Company’s
D&O insurance policies, if available, and any other insurance policies that protect employees and contractors as in effect from time
to time. Such insurance policies shall be with providers, and provide for coverage in amounts, customary and reasonable within the industry
in which the Company operates.
9. Restrictive
Covenants.
(a) Proprietary
Information.
(i) Management
Company agrees that all information and know-how, whether or not in writing, of a private, secret or confidential nature concerning the
business or financial affairs of the Company or any Affiliates (as defined in Section 7(f) below) is and shall be the exclusive property
of the Company or any Affiliates. Such information and know-how shall include, but not be limited to, inventions, products, processes,
methods, techniques, formulas, compositions, compounds, projects, developments, plans, research data, clinical data, financial data,
personnel data, computer programs, customer and supplier lists, client lists, business plans, operational methods, pricing policies,
marketing plans, sales plans, identity of suppliers or vendors, trading positions, sales, profits or other financial or business information,
in each case of or relating to the business of the Company or any Affiliates (collectively, “Proprietary Information”).
Except in connection with, and on a basis consistent with, the performance of his duties hereunder, Management Company shall not disclose
any Proprietary Information to others outside the Company or any Affiliates or use the same for any unauthorized purposes without written
approval by the Board, either during or at any time after the Services Period.
(ii) Management
Company agrees that all files, letters, memoranda, reports, records, data, sketches, drawings, laboratory notebooks, program listings,
customer lists, customer solicitations or other written, photographic, or other tangible material containing Proprietary Information,
whether created by Management Company or others, which shall come into his custody or possession, shall be and are the exclusive property
of the Company or any Affiliates to be used by Management Company only in the performance of his duties for the Company. Management Company
agrees to deliver to the Company upon the expiration of the Services Period all such material containing Proprietary Information.
(iii) Management
Company agrees that his obligation not to disclose or use information, know-how and records of the types set forth in paragraphs (i)
and (ii) above, also extends to such types of information, know-how, records and tangible property of customers of the Company or any
Affiliates or suppliers to the Company or any Affiliates or other third parties who may have disclosed or entrusted the same to the Company
or any Affiliates or to Management Company in the course of the Company’s business.
(iv)
Notwithstanding the foregoing, Proprietary Information shall not include information which (A) is or becomes generally available or known
to the public, other than as a result of any disclosure by Management Company in violation hereof; or (B) is or becomes available to
Management Company on a non-confidential basis from any source other than the Company, other than any such source that is known to Management
Company to be prohibited by a legal, contractual, or fiduciary obligation to the Company from disclosing such information.
(v) In
the event that Management Company is requested pursuant to, or becomes compelled by, any applicable law, regulation, or legal process
to disclose any Proprietary Information, Management Company shall provide the Company with prompt written notice thereof so that the
Company may seek a protective order or other appropriate remedy or, in the Company’s sole and absolute discretion, waive compliance
with the terms hereof. In the event that no such protective order or other remedy is obtained, or the Company waives compliance with
the terms hereof, Management Company shall furnish only that portion of such Proprietary Information which Management Company is advised
by counsel in writing is legally required. Management Company will cooperate with the Company, at the Company’s sole cost and expense,
in its efforts to obtain reliable assurance that confidential treatment will be accorded such Proprietary Information.
(b) Developments.
(i) Management
Company shall make full and prompt disclosure to the Company of all inventions, improvements, discoveries, methods, developments, software,
and works of authorship, whether patentable or not, which are created, made, conceived or reduced to practice by Management Company or
under his direction or jointly with others during the Services Period, whether or not during normal working hours or on the premises
of the Company or any Affiliates (collectively, “Developments”).
(ii) Management
Company agrees to assign and does hereby assign to the Company (or any entity designated by the Company) all of his right, title and
interest in and to all Developments and all related patents, patent applications, copyrights, copyright applications, trademark and trademark
applications and other intellectual property of any kind or nature. Management Company also hereby waives all claims to moral rights
in any Developments.
(iii) Management
Company agrees to cooperate fully with the Company or any Affiliates, both during and after the Services Period, with respect to the
procurement, maintenance and enforcement of copyrights and patents (both in the United States and foreign countries) relating to Developments.
Management Company shall sign all papers, including, without limitation, copyright applications, patent applications, declarations, oaths,
formal assignments, assignment of priority rights, and powers of attorney, which the Company or any Affiliates may deem necessary or
desirable in order to protect their rights and interests in any Development.
(c) Other
Agreements. Management Company represents that his performance of all the terms of this Agreement and as an contractor of the Company
does not and will not breach any agreement (i) to keep in confidence proprietary information, knowledge or data acquired by him in confidence
or in trust prior to his services to the Company, (ii) to refrain from competing, directly or indirectly, with the business of his previous
employer or any other party, and (iii) to refrain from soliciting the employment of any employees of any previous employer or any other
party.
(d) Non-Competition
and Non-Solicitation. During any period of Management Company’s services hereunder and for a period of one (1) year thereafter,
Management Company shall not engage (whether as an employee, consultant, director, agent or independent contractor) in any Business Activities
on behalf of himself or any person, firm or entity, and Management Company shall not acquire any financial interest (except for equity
interests in publicly-held companies that will not be significant and that, in any event, will not exceed one percent (1%) of the outstanding
equity of such company) in any entity which engages in Business Activities in the geographic area of the United States. During the period
that the above noncompetition restriction applies, Management Company shall not, without the written consent of the Company: (i) solicit
any employee of the Company or any Affiliates to terminate his employment, or (ii) solicit any customers, partners, resellers, vendors
or suppliers of the Company on behalf of any individual or entity other than the Company or its Affiliates. As used herein, the term
“Business Activities” shall mean any and all business activities of the Company and any Affiliates as presently
conducted and/or conducted for the past two (2) years.
(e) Enforcement.
The Company shall be entitled to seek a restraining order or injunction in any court of competent jurisdiction to prevent any continuation
of any violation of the provisions of this Section 7.
(f) Affiliates.
For purposes of this Agreement, Affiliates shall mean any individuals or entities that directly or indirectly, through one or more intermediaries,
controls, are controlled by or are under common control with the Company. For purposes of this definition, “control” means
the power to direct the management and policies of another, whether through the ownership of voting securities, by contract or otherwise.
10. Provisions
Relating to Possible Excise Tax.
(a) Cut-Back
to Maximize Retained After-Tax Amounts. The Company will reduce any payment relating to a Change in Control (with a “payment”
including, without limitation, the vesting of an option or other non-cash benefit or property) pursuant to any plan, agreement or arrangement
of the Company (together, “Severance Payments”) to the Reduced Amount (as defined below) if but only if reducing
the Severance Payment would provide to Management Company a greater net after-tax amount of Severance Payments than would be the case
if no such reduction took place. The “Reduced Amount” shall be an amount expressed in present value which maximizes
the aggregate present value of the Severance Payments without causing any Severance Payment to be subject to the excise tax under Section
4999 (and related Section 280G) of the Code, determined in accordance with Section 280G(d)(4) of the Code. Any reduction in Severance
Payments shall be implemented in accordance with Section 8(b).
(b) Implementation
Rules. Any reduction in payments under Section 8(a) shall apply to cash payments and/or vesting of equity awards so as
to minimize the amount of compensation that is reduced (i.e., it applies to payments or vesting that to the greatest extent represent
parachute payments), with the amount of compensation based on vesting to be measured (to be minimally reduced, for purposes of this provision)
by the intrinsic value of the equity award at the date of such vesting. Management Company will be advised of the determination as to
which compensation will be reduced and the reasons therefor, and Management Company and his advisors will be entitled to present information
that may be relevant to this determination. No reduction shall be applied to an amount that constitutes a deferral of compensation under
Code Section 409A except for amounts that have become payable at the time of the reduction and as to which the reduction will not result
in a non-reduction in a corresponding amount that is a deferral of compensation under Code Section 409A that is not currently payable.
For purposes of determining whether any of the Severance Payments will be subject to the Excise Tax and the amount of such Excise Tax:
(i) The
Severance Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all
“excess parachute payments” within the meaning of Section 280G(b)(1) of the Code shall be treated as subject to the Excise
Tax, unless, and except to the extent that, in the written opinion of independent compensation consultants, counsel or auditors of nationally
recognized standing (“Independent Advisors”) selected by the Company and reasonably acceptable to a majority
of the employees who have Change in Control Agreements, the Severance Payments (in whole or in part) do not constitute parachute payments,
or such excess parachute payments (in whole or in part) represent reasonable compensation for services actually rendered within the meaning
of Section 280G(b)(4) of the Code in excess of the base amount within the meaning of Section 280G(b)(3) of the Code or are otherwise
not subject to the Excise Tax.
(ii) The
value of any non-cash benefits or any deferred payment or benefit shall be determined by the Independent Advisors in accordance with
the principles of Sections 280G(d)(3) and (4) of the Code.
For
purposes of determining reductions in compensation under Section 8(b), if any, Management Company will be deemed (A) to pay federal income
taxes at the applicable rates of federal income taxation for the calendar year in which the compensation would be payable; and (B) to
pay any applicable state and local income taxes at the applicable rates of taxation for the calendar year in which the compensation would
be payable, taking into account any effect on federal income taxes from payment of state and local income taxes. Compensation will be
adjusted not later than the applicable deadline under Code Section 409A to provide for accurate payments under the cut-back provision
of Section 8(b), but after any such deadline no further adjustment will be made if it would result in a tax penalty under Section 409A.
(c) Internal
Revenue Service Proceedings. The Company shall have the right to control all proceedings with the Internal Revenue Service (or
relating thereto) that may arise in connection with the determination and assessment of any Excise Tax and, at its sole option, the Company
may pursue or forego any and all administrative appeals, proceedings, hearings, and conferences with any taxing authority in respect
of such Excise Tax (including any interest or penalties thereon); provided, however, that the Company’s control
over any such proceedings shall be limited to issues with respect to which compensation may be reduced hereunder, and Management Company
will be entitled to settle or contest any other issue raised by the Internal Revenue Service or any other taxing authority. Management
Company agrees to cooperate with the Company in any proceedings relating to the determination and assessment of any Excise Tax.
11. Section
409A Compliance Rules.
(a) In
General. This Section 9 serves to ensure compliance with applicable requirements of Section 409A. Certain provisions of this
Section 9 modify other provisions of this Agreement. If the terms of this Section 9 conflict with other terms of the Agreement, the terms
of this Section 9 shall control.
(b) Timing
of Certain Payments. Unless an amount is payable under a plan, program or arrangement on explicit terms providing for a delay
in payment after Termination, which terms comply with Section 409A, amounts earned or accrued as of the Date of Termination shall be
payable at the date the amounts otherwise would have been payable under the respective plans, programs and arrangements but in no event
more than sixty (60) days after Management Company’s Termination. Any payment or benefit required under this Agreement to be paid
in a lump sum or otherwise to be paid promptly at or following a date or event shall be paid no later than fifteen (15) days after the
due date, subject to Section 9(d) below. In the case of any payment under the Agreement payable during a specified period of time following
a Termination or other event, if such permitted payment period begins in one calendar year and ends in a subsequent calendar year, Management
Company shall have no right to elect in which year the payment will be made, and the Company’s determination of when to make the
payment shall not be influenced in any way by Management Company.
(c) Separate
Payments. Each installment payment payable under Section 5(b)(i), and each portion of an installment payment that would be payable
under Section 5(b)(iii) (together, the “Separate 5(b) Payments”), and the payment payable under Section 5(c)
in excess of the payments under Section 5(b) (the “Separate 5(c) Payment”) (or in each the present value thereof,
if such present valuing is required to comply with Section 409A) shall be deemed a separate payment for all purposes, including for purposes
of Section 409A. Each other amount payable under this Agreement shall be deemed a separate payment for all purposes, including for purposes
of Section 409A.
(d) Special
Rules for Severance Payments. In the case of severance payments payable under Section 5(b)(i) and 5(c) (the “Severance
Payments”):
(i) In
the case of Separate 5(b) Payments, those payments that do not qualify as short term deferrals under Treasury Regulation § 1.409A-1(b)(4)
shall be exempted, to the maximum extent of the “two-year/two-times” exclusion under Treasury Regulation § 1.409A-1(b)(9)(iii),
first as to those such Separate 5(b) Payments payable within six (6) months of Termination and then as to the latest of those such Separate
5(b) Payments payable in reverse order of payment.
(ii) If
either (A) the Change in Control does not involve a transaction that constitutes a change in the ownership of the Company, a change in
effective control of the Company, or a change in the ownership of a substantial portion of the assets of the Company as defined in Treasury
Regulation § 1.409A-3(i)(5) (a “409A Change in Control”), or (B) Management Company’s Termination
triggering payments hereunder did not occur within the two-year period following a 409A Change in Control, any portion of the Severance
Payments that constitute a deferral of compensation under Code Section 409A and which correspond to the Separate 5(b) Payments shall
be payable at the time specified for such payments under Section 5(b) rather than under Section 5(c), subject to subsection (iii) below.
(iii) As
to any payment under this Agreement (including any portion of the Severance Payments) that constitutes a deferral of compensation under
Code Section 409A, the term Termination shall mean a “separation from service” as defined in Treasury Regulation § 1.409A-1(h).
If any of such payments is payable within six (6) months after Management Company’s Termination and, at the time of Termination,
Management Company was a “specified employee” as defined in Treasury Regulation § 1.409A-1(i), such payment shall instead
be paid at the date that is six (6) months after Management Company’s Termination (or earlier at the date fifteen (15) days after
the death of Management Company).
(e) Other
Provisions.
(i) Non-transferability.
No right to any payment or benefit under this Agreement shall be subject to anticipation, alienation, sale, transfer, assignment, pledge,
encumbrance, attachment, or garnishment by Management Company’s creditors or of any of Management Company’s beneficiaries.
(ii) No
Acceleration. The timing of payments and benefits under the Agreement may not be accelerated to occur before the time specified
for payment hereunder, except to the extent permitted under Treasury Regulation § 1.409A-3(j)(4) or as otherwise permitted under
Section 409A without Management Company incurring a tax penalty.
(iii) Intention
to Comply with Code Section 409A; Modifications. To the fullest extent possible, payments and benefits provided under this Agreement
are intended to be exempt or excluded from the definition of “deferred compensation” under Section 409A in accordance with
one or more exemptions or exclusions available under Section 409A. If and to the extent that any such payment or benefit is, or becomes
subject to, Section 409A due to a failure to qualify for such an exemption or exclusion, this Agreement is intended to comply with the
applicable requirements of Section 409A with respect to such payment or benefit so as to avoid the imposition of any taxes and/or penalties
due to a violation of Section 409A. To the extent possible, this Agreement shall be interpreted and administered in a manner consistent
with the foregoing statement of intent. This Agreement may be modified in order to comply with Section 409A or exemptions or exclusions
under Section 409A; any such modification shall be made in good faith and to the extent reasonably practical shall maintain the economic
and other benefits provided to Management Company and the Company under this Agreement without failing to comply with Section 409A.
(iv) Company
Not Liable for Non-Compliance with Section 409A. In no event whatsoever (including without limitation as a result of this Section
9) shall the Company be liable for any taxes, penalties or interest that may be imposed on Management Company pursuant to Code Section
409A or under any similar provision of state tax law, including by not limited to damages for failing to comply with Section 409A and/or
any similar provision of state tax law.
12. Notices. Any
notice or other communication required or permitted to be given to any party hereunder shall be in writing and shall be given to such
party at such party’s address set forth below or such other address as such party may hereafter specify by notice in writing to
the other party. Any such notice or other communication shall be addressed as aforesaid and given by (a) certified mail, return receipt
requested, with first class postage prepaid, (b) hand delivery, or (c) reputable overnight courier. Any notice or other communication
will be deemed to have been duly given (i) on the fifth day after mailing, provided receipt of delivery is confirmed, if mailed by certified
mail, return receipt requested, with first class postage prepaid, (ii) on the date of service if served personally or (iii) on the business
day after delivery to an overnight courier service, provided receipt of delivery has been confirmed:
| If
to the Company: |
Healthcare
Integrated Technologies, Inc.
311
S. Weisgarber Road |
| |
Knoxville,
TN 37919 |
| |
|
| If
to Management Company: |
All
Things New Ventures, LLC |
13. Non-Assignment;
Successors. Neither party hereto may assign his or its rights or delegate his or its duties under this Agreement without
the prior written consent of the other party, provided that, the Company may assign its rights hereunder to any affiliate or successor
entity. This Agreement shall inure to the benefit of and be binding upon the heirs, assigns or designees of the parties hereto. The Company
shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all
of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company”
shall mean the Company as hereinbefore defined and any such successor to its business and/or assets which assumes and agrees to perform
this Agreement by operation of law, or otherwise.
14. Entire
Agreement. This Agreement constitutes the entire agreement by the Company and Management Company with respect to the subject
matter hereof and supersedes any and all prior agreements or understandings between Management Company and the Company with respect to
the subject matter hereof, whether written or oral, including, without limitation, that certain Non-Employee Chief Strategy Officer Engagement
Agreement dated as of June 15, 2024.
15. Amendment
and Waiver. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance, either retroactively or prospectively, and either for a specified period of time or indefinitely),
only by the written consent of all parties hereto. Any agreement on the part of a party to any extension or waiver shall only be valid
if set forth in an instrument in writing signed on behalf of such party. Any such waiver or extension shall not operate as waiver or
extension of any other subsequent condition or obligation.
16. Unenforceability,
Severability. If any provision of this Agreement is found to be void or unenforceable by a court of competent jurisdiction, the
remaining provisions of this Agreement shall nevertheless be binding upon the parties with the same force and effect as though the unenforceable
part had been severed and deleted.
17. Specific
Performance. The parties hereto agree that irreparable damage would occur if any of the provisions of this Agreement were not
performed in accordance with their specific terms or otherwise breached. It is accordingly agreed that the parties shall be entitled
to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in
addition to any other remedy to which they are entitled at law or in equity.
18. Mitigation.
Management Company will not be required to mitigate the amount of payments provided for under this Agreement by seeking other employment
or otherwise, nor shall the amount of payments provided for under this Agreement be reduced by any compensation earned by Management
Company as the result of employment by another employer, by retirement benefits, by offset against any amount claimed to be owed by Management
Company to the Company, or otherwise.
19. Governing
Law. This Agreement shall be construed, interpreted and enforced in accordance with, and shall be governed by, the laws of the
State of Tennessee applicable to contracts made and to be performed wholly therein without giving effect to principles of conflicts or
choice of laws thereof.
20. Jurisdiction.
Each of the parties hereto hereby irrevocably consents and submits to the exclusive jurisdiction of the state and federal courts located
in Knox County, Tennessee in connection with any proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby and waives any objection to venue in Knox County, Tennessee. In addition, each of the parties hereto hereby waives trial by jury
in connection with any claim or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
21. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together
will constitute one and the same instrument.
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Agreement Date.
| All
Things New Ventures, LLC |
|
| |
|
| /s/
Dustin Hillis |
|
| Dustin
Hillis |
|
| |
|
|
| Healthcare
Integrated Technologies, Inc. |
|
| |
|
| /s/
Scott M. Boruff |
|
| By:
|
Scott
M. Boruff |
|
| Its:
|
Chairman
& CEO |
|
v3.25.0.1
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
Healthcare Integrated Te... (PK) (USOTC:HITC)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Healthcare Integrated Te... (PK) (USOTC:HITC)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
